We are live on ! Find out more
SQZ

SQZ Biotechnologies Company
SQZ

Delisted

SQZ was delisted on the 3rd of July, 2023.

Back to rankings

5 hedge funds and large institutions have $333K invested in SQZ Biotechnologies Company in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

84% less funds holding

Funds holding: 31 → 5 (-26)

89% less capital invested

Capital invested by funds: $2.96M → $333K (-$2.63M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 26

Holders
5
Holders Change
-26
Holders Change %
-83.87%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
26
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Temasek Holdings
Temasek Holdings
Singapore
-$745K
2
MC
Maverick Capital
Texas
-$284K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$254K
4
Stifel Financial
Stifel Financial
Missouri
-$230K
5
LCM
Laurion Capital Management
New York
-$111K
Name Holding Trade Value Shares
Change 		Change in
Stake
AIG
1
American International Group
New York
$202K – – –
AG
2
Artal Group
Luxembourg
$129K – – –
BTI
3
Blue Trust Inc
Georgia
$1K – – –
BSB
4
Bangor Savings Bank
Maine
$911 – – –
Barclays
5
Barclays
United Kingdom
$144 – – –
Temasek Holdings
6
Temasek Holdings
Singapore
– -$745K -2,758,169 Closed
MC
7
Maverick Capital
Texas
– -$284K -1,050,286 Closed
Vanguard Group
8
Vanguard Group
Pennsylvania
– -$254K -941,086 Closed
Stifel Financial
9
Stifel Financial
Missouri
– -$230K -851,520 Closed
LCM
10
Laurion Capital Management
New York
– -$111K -412,865 Closed
Geode Capital Management
11
Geode Capital Management
Massachusetts
– -$36.5K -135,360 Closed
Renaissance Technologies
12
Renaissance Technologies
New York
– -$23K -83,603 Closed
Millennium Management
13
Millennium Management
New York
– -$21.9K -80,938 Closed
RC
14
RBF Capital
California
– -$20.2K -74,674 Closed
BCM
15
Bridgeway Capital Management
Texas
– -$17.8K -65,800 Closed
BlackRock
16
BlackRock
New York
– -$17.5K -64,677 Closed
State Street
17
State Street
Massachusetts
– -$15.2K -56,140 Closed
SCA
18
Sandy Cove Advisors
Massachusetts
– -$14K -51,707 Closed
SG Americas Securities
19
SG Americas Securities
New York
– -$12K -43,420 Closed
Prudential Financial
20
Prudential Financial
New Jersey
– -$10.9K -40,200 Closed
Northern Trust
21
Northern Trust
Illinois
– -$8.38K -31,022 Closed
Susquehanna International Group
22
Susquehanna International Group
Pennsylvania
– -$7.89K -29,231 Closed
Morgan Stanley
23
Morgan Stanley
New York
– -$4.63K -17,135 Closed
Goldman Sachs
24
Goldman Sachs
New York
– -$4.29K -15,896 Closed
HSBC Holdings
25
HSBC Holdings
United Kingdom
– -$3.11K -11,440 Closed
1
2

SQZ Hedge Fund Activity: Q3 2023 in Review

5 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in SQZ Biotechnologies Company (SQZ) for Q3 2023, worth a combined $333K — down 89% from $2.96M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of SQZ and 0 opened new positions — a net loss of 26 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Temasek Holdings, exiting entirely with an estimated $745K sold.

  • 5 institutional investors held SQZ Biotechnologies Company (SQZ) as of Q3 2023, down from 31 in Q2 2023.
  • Funds reported $333K of SQZ Biotechnologies Company stock for Q3 2023, down 89% quarter-over-quarter.
  • 0 funds opened new SQZ Biotechnologies Company positions in Q3 2023 and 26 closed out, a net change of -26 holders.
  • The largest SQZ Biotechnologies Company seller in Q3 2023 was Temasek Holdings, an estimated $745K sold.

Based on aggregated 13F filings for Q3 2023.